{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:02:54Z","timestamp":1789124574989,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["U01FD005942"],"award-info":[{"award-number":["U01FD005942"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K23NS101096-01A1"],"award-info":[{"award-number":["K23NS101096-01A1"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R21NS128391"],"award-info":[{"award-number":["1R21NS128391"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013301","name":"Parkinson's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008444","name":"Parkinsonfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011944","name":"School of Public Health, University of California Berkeley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011944","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ajgponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jagp.2023.12.024","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:07:13Z","timestamp":1704326833000},"page":"710-720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Association of Antidepressant Use and Impulse Control Disorder in Parkinson's Disease"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4600-1802","authenticated-orcid":false,"given":"Christopher B.","family":"Morrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared T.","family":"Hinkle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Seemiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Pontone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2023.12.024_bib0001","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1474-4422(21)00330-6","article-title":"The neuropsychiatry of Parkinson's disease: advances and challenges","volume":"21","author":"Weintraub","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jagp.2023.12.024_bib0002","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.parkreldis.2013.07.010","article-title":"Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease","volume":"19","author":"Muller","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jagp.2023.12.024_bib0003","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41583-021-00542-9","article-title":"Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?","volume":"23","author":"Blesa","year":"2022","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jagp.2023.12.024_bib0004","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jagp.2023.12.024_bib0005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/bs.irn.2017.04.006","article-title":"Impulse control and related disorders in Parkinson's disease","volume":"133","author":"Weintraub","year":"2017","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.jagp.2023.12.024_bib0006","doi-asserted-by":"crossref","first-page":"967","DOI":"10.4103\/0028-3886.237019","article-title":"Impulse control disorders in Parkinson's disease: review of pathophysiology, epidemiology, clinical features, management, and future challenges","volume":"66","author":"Bhattacharjee","year":"2018","journal-title":"Neurol India"},{"key":"10.1016\/j.jagp.2023.12.024_bib0007","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11612","article-title":"Prevalence of impulsive-compulsive symptoms in elderly Parkinson's disease patients: a case-control study","volume":"79","author":"Lo Monaco","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jagp.2023.12.024_bib0008","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fneur.2019.00086","article-title":"Medications, deep brain stimulation, and other factors influencing impulse control disorders in Parkinson's disease","volume":"10","author":"Eisinger","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.jagp.2023.12.024_bib0009","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.jagp.2023.12.024_bib0010","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1399-5618.2003.00067.x","article-title":"Antidepressant-induced mania: an overview of current controversies","volume":"5","author":"Goldberg","year":"2003","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jagp.2023.12.024_bib0011","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.4088\/JCP.v68n1002","article-title":"Self-reported history of manic\/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"68","author":"Truman","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jagp.2023.12.024_bib0012","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.2014.13111501","article-title":"The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer","volume":"171","author":"Viktorin","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2023.12.024_bib0013","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.parkreldis.2014.01.001","article-title":"Hypomania and mania related to dopamine replacement therapy in Parkinson's disease","volume":"20","author":"Maier","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jagp.2023.12.024_bib0014","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/bdi.12067","article-title":"Could pramipexole induce acute mania? A case report","volume":"15","author":"Bet","year":"2013","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jagp.2023.12.024_bib0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1176\/ajp.2007.164.2.351","article-title":"A case of mania following the use of pramipexole","volume":"164","author":"Sharma","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2023.12.024_bib0016","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1176\/appi.ajp.162.4.814-a","article-title":"Pramipexole, ropinirole, and mania in Parkinson's disease","volume":"162","author":"Singh","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2023.12.024_bib0017","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1176\/ajp.152.8.1130","article-title":"Antidepressant-induced mania and cycle acceleration: a controversy revisited","volume":"152","author":"Altshuler","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2023.12.024_bib0018","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4088\/JCP.v59n0706","article-title":"Bipolar depression and antidepressant-induced mania: a naturalistic study","volume":"59","author":"Boerlin","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jagp.2023.12.024_bib0019","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1192\/bjp.164.4.549","article-title":"Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants","volume":"164","author":"Peet","year":"1994","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jagp.2023.12.024_bib0020","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/bmj.2.5159.1052","article-title":"A controlled trial of imipramine in treatment of depressive states","volume":"2","author":"Ball","year":"1959","journal-title":"Br Med J"},{"key":"10.1016\/j.jagp.2023.12.024_bib0021","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1192\/bjp.105.441.1123","article-title":"The treatment of depressive states with imipramine hydrochloride (Tofranil)","volume":"105","author":"Leyberg","year":"1959","journal-title":"J Ment Sci"},{"key":"10.1016\/j.jagp.2023.12.024_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227128","article-title":"What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson's disease? A preliminary pharmacoepidemiologic study","volume":"15","author":"Jeon","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jagp.2023.12.024_bib0023","doi-asserted-by":"crossref","first-page":"e00904","DOI":"10.1002\/brb3.904","article-title":"Impulse control disorders in Parkinson's: sleep disorders and nondopaminergic associations","volume":"8","author":"Carbunaru","year":"2018","journal-title":"Brain Behav"},{"key":"10.1016\/j.jagp.2023.12.024_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105918","article-title":"Examining the link between impulse control disorder and antidepressant use in Parkinson's disease","volume":"117","author":"Morrow","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jagp.2023.12.024_bib0025","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","article-title":"The Parkinson Progression Marker Initiative (PPMI)","volume":"95","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jagp.2023.12.024_bib0026","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/mds.22571","article-title":"Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease","volume":"24","author":"Weintraub","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.jagp.2023.12.024_bib0027","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/mds.24023","article-title":"Questionnaire for impulsive-compulsive disorders in Parkinson's Disease-Rating Scale","volume":"27","author":"Weintraub","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.jagp.2023.12.024_bib0028","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/acn3.51569","article-title":"Genetic prediction of impulse control disorders in Parkinson's disease","volume":"9","author":"Weintraub","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jagp.2023.12.024_bib0029","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s42466-021-00157-6","article-title":"An updated calculator for determining levodopa-equivalent dose","volume":"3","author":"Nyholm","year":"2021","journal-title":"Neurol Res Pract"},{"key":"10.1016\/j.jagp.2023.12.024_bib0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: a preliminary report","volume":"17","author":"Yesavage","year":"1982","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jagp.2023.12.024_bib0031","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/mds.21023","article-title":"Validity of the 30-item geriatric depression scale in patients with Parkinson's disease","volume":"21","author":"McDonald","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.jagp.2023.12.024_bib0032","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archinte.1997.00440250107012","article-title":"Screening for depression in elderly primary care patients. A comparison of the Center for Epidemiologic Studies-Depression Scale and the Geriatric Depression Scale","volume":"157","author":"Lyness","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jagp.2023.12.024_bib0033","article-title":"Impulse control disorders in Parkinson's disease: epidemiology, pathogenesis and therapeutic strategies","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jagp.2023.12.024_bib0034","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/21556660.2019.1675670","article-title":"Risk factors for impulse control disorders and related behaviors in Parkinson's disease: secondary analyses of the ICARUS study","volume":"8","author":"Barone","year":"2019","journal-title":"J Drug Assess"},{"key":"10.1016\/j.jagp.2023.12.024_bib0035","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1345\/aph.19313","article-title":"Mania with bupropion: a dose-related phenomenon?","volume":"34","author":"Goren","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jagp.2023.12.024_bib0036","doi-asserted-by":"crossref","first-page":"e3165","DOI":"10.1097\/MD.0000000000003165","article-title":"Significant treatment effect of bupropion in patients with bipolar disorder but similar phase-shifting rate as other antidepressants: a meta-analysis following the PRISMA guidelines","volume":"95","author":"Li","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jagp.2023.12.024_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2022.107329","article-title":"The effect of Varenicline and Bupropion on smoking cessation: a network meta-analysis of 20 randomized controlled trials","volume":"131","author":"Guo","year":"2022","journal-title":"Addict Behav"},{"key":"10.1016\/j.jagp.2023.12.024_bib0038","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(10)60888-4","article-title":"Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"376","author":"Greenway","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jagp.2023.12.024_bib0039","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0014-2999(00)00566-5","article-title":"The role of dopamine in the mechanism of action of antidepressant drugs","volume":"405","author":"D'Aquila","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jagp.2023.12.024_bib0040","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5663274","article-title":"The effects of citalopram and thalamic dopamine D(2\/3) receptor availability on decision-making and loss aversion in alcohol dependence","volume":"2022","author":"Zorick","year":"2022","journal-title":"Psychiatry J"},{"key":"10.1016\/j.jagp.2023.12.024_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/syn.20574","article-title":"Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography","volume":"63","author":"Smith","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.jagp.2023.12.024_bib0042","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mp.2017.16","article-title":"The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment","volume":"22","author":"Ashok","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jagp.2023.12.024_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2022.791749","article-title":"A role for serotonin in modulating opposing drive and brake circuits of impulsivity","volume":"16","author":"Desrochers","year":"2022","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.jagp.2023.12.024_bib0044","doi-asserted-by":"crossref","first-page":"e13264","DOI":"10.1111\/adb.13264","article-title":"Serotonergic and dopaminergic control of impulsivity in gambling disorder","volume":"28","author":"Kaasinen","year":"2023","journal-title":"Addict Biol"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748123005304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748123005304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T13:55:23Z","timestamp":1728914123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748123005304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1064748123005304"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2023.12.024","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Association of Antidepressant Use and Impulse Control Disorder in Parkinson's Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2023.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}